Autophagy Inhibitor (LY294002) and 5-fluorouracil (5-FU) Combination-Based Nanoliposome for Enhanced Efficacy Against Esophageal Squamous Cell Carcinoma

In this study, 5-fluorouracil (5-FU) and LY294002 (LY)-loaded PEGylated nanoliposome was prepared to target esophageal squamous cell carcinoma (ESCC). The particles were characterized in terms of physicochemical and biological parameters. The co-delivery of autophagy inhibitor and chemotherapeutic d...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Ye, Gao, Yongjian, Wang, Dayu, Xu, Zhonghang, Sun, Weixuan, Ren, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Nano Express
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192941/
https://www.ncbi.nlm.nih.gov/pubmed/30328537
http://dx.doi.org/10.1186/s11671-018-2716-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192941/
https://www.ncbi.nlm.nih.gov/pubmed/30328537
http://dx.doi.org/10.1186/s11671-018-2716-x

Ejemplares similares